LPL Financial announced that FHT Advisors and Impel Wealth Management, two Ohio-based financial firms managing about $1.15 billion in client assets, have joined its broker-dealer and Registered Investment Advisor platforms. Both firms will maintain their separate identities while benefiting from LPL's technology and resources to enhance client services and support complex financial needs. The partnership aims to leverage collaborative advisory approaches and advanced planning capabilities to improve client experiences and foster growth. This move strengthens LPL's position as a leading wealth management firm in the U.S.
LPL Financial's recent partnership news offers context for Financials-sector stocks on Pluang. For readers following Financials, here is Pluang's market snapshot as of Nov 10, 2026 19:43 WIB: Out of 142 priced Financials-sector US stocks, 98 rose and 35 fell. Notable movers include HUT at USD 55.94 with a 1-day change of -1.89% and Pluang order activity of 72% Sell / 28% Buy, CLSK at USD 6.78 down 1.88% with 9% Sell / 91% Buy, and BSBR at USD 5.00 up 1.83% with 33% Sell / 67% Buy.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
